Major depression and coronary flow reserve detected by positron emission tomography

Viola Vaccarino1, John Votaw, Tracy Faber

  • 1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30306, USA. viola.vaccarino@emory.edu

Insights

Major depressive disorder (MDD) is linked to coronary heart disease (CHD) risk, potentially through shared genetics affecting microvascular function. This study found reduced coronary flow reserve in twins with MDD, suggesting a genetic link to heart disease.

Area of Science:

  • Cardiology
  • Psychiatry
  • Genetics

Background:

  • Major depressive disorder (MDD) is associated with coronary heart disease (CHD), but underlying mechanisms remain unclear.
  • MDD may increase CHD risk via microvascular circulation changes or shared genetic factors.
  • Coronary flow reserve (CFR) is a measure of microvascular function.

Purpose of the Study:

  • To investigate the relationship between MDD and CFR.
  • To explore potential shared genetic pathways between MDD and microvascular dysfunction.

Main Methods:

  • Examined 289 male middle-aged twins, including 106 discordant for MDD and 183 controls.
  • Measured CFR using positron emission tomography with (13)N-ammonia for myocardial blood flow.
  • Assessed myocardial ischemia using a standard perfusion defect score.

Main Results:

  • No significant difference in myocardial ischemia between twins with and without MDD.
  • Dizygotic twins with MDD showed a 14% lower CFR compared to their non-MDD brothers (P = .03).
  • This association was absent in monozygotic twins, indicating a genetic influence (zygosity-MDD interaction P = .006).

Conclusions:

  • Results suggest a shared genetic pathway linking MDD and microvascular dysfunction.
  • Common pathophysiological processes may connect MDD and early atherosclerosis development.
Abstract

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...